肉毒毒素:当然,我们可以做得更好吗? 优化结果超越标签上的技术和教学
Aesthetic surgery journal. Open forum
|June 30, 2025
概括
标准的肉毒毒素 (BoNTA) 注射技术可能会导致不自然的面部外观. 根据个体解剖学和功能量身定制治疗对于最佳的美学结果至关重要,超越通用协议.
科学领域:
- 审美医学是一种美学医学.
- 面部解剖学 面部解剖学
- 神经调节是一种神经调节.
背景情况:
- 面部表情对于沟通至关重要.
- 毒素 (BoNTA) 用于减少纹,但可能导致不良影响.
- 低于最佳的BoNTA注射会导致不良的美学结果.
研究的目的:
- 调查标准"标签上"的BoNTA注射技术是否有助于结果差.
- 确定导致BoNTA治疗中不理想结果的因素.
- 为改善注射技术提供建议.
主要方法:
- 一个共识小组审查了相关的解剖学,表达和并发症.
- 使用了数据库查询和专家意见.
- 分析的重点是"标签上的"治疗方案及其结果.
主要成果:
- 解剖学变异和通用注射模式会导致低于最佳的结果,如眉毛亡和不自然的微笑.
- "标签上的"协议往往无法解释个体患者的解剖学和功能.
- 调整剂量,深度,位置和治疗相关肌肉是关键的解决方案.
结论:
- 标准的"标签上的"BoNTA技术可能会导致不自然的面部外观.
- 根据个体解剖学和功能量身定制注射策略对于优化结果至关重要.
- 为获得更好的结果,建议超越通用协议,采用个性化的方法.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
772
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
772
Skeletal Muscle Relaxants: Therapeutic Uses
631
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
631
Depolarizing Blockers: Pharmocokinetics
389
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
389
Prevention of Further Absorption of Poison
934
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
934
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
547
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
547
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
847
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
847


